Zenas BioPharma, Inc. share price logo

Zenas BioPharma, Inc.

NASDAQ: ZBIO

Mid Cap

$31.47

-0.50

(-1.56%)

Live

as on

Zenas BioPharma, Inc. Stock Performance

as on September 19, 2026 at 5:12 am IST

  • Day's Low

    Day's High

    $31.25
    $31.91
    downward going graph

    0.70%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $13.50
    $44.60
    downward going graph

    57.10%

    Downside

    41.72%

    Upside

    downward going graph

Zenas BioPharma, Inc. share price movements today

Previous Close
$31.97
Open
$31.82
Volume
214.8K
Market Cap
$2.1B
Day's Low - High
$31.25 - $31.91
52 Week Low - High
$13.50 - $44.60

Zenas BioPharma, Inc. Historical Returns

1 Month Return
+ 0.19 %
3 Month Return
+ 61.63 %
1 Year Return
+ 64.29 %
3 Year Return
0 %
5 Year Return
0 %

Zenas BioPharma, Inc. Stock Fundamentals & Key Indicators

Check Zenas BioPharma, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-9.62

Dividend Yield

0.00%

PE Ratio (TTM)

-3.32

Industry PE ratio

-13.55

PEG Ratio

0.037361978480889

Return On Equity TTM

-189.68%

Zenas BioPharma, Inc. Stock Valuation

Track how Zenas BioPharma, Inc. P/E has moved over time to understand its valuation trends.

Zenas BioPharma, Inc. in the last 4 years

  • Overview

  • Trends

Lowest (-18.55x)

December 31, 2023

Industry (-13.55x)

December 31, 2025

Today (-4.30x)

December 31, 2025

Highest (-2.18x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -4.30x

Zenas BioPharma, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zenas BioPharma, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Zenas BioPharma, Inc. image
Zenas BioPharma, Inc.
StrongBuy$2.1BNA-3.32-5972.60%0.00%
Moderna image
Moderna
BUY$63.1B-63.24%-19.81-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.1B174.21%29.8186.04%0.00%
Regeneron image
Regeneron
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Zenas BioPharma, Inc. Stock including INR - Dollar returns

The Zenas BioPharma, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 7Y

  • 10Y

Zenas BioPharma, Inc. investment value today

Current value as on today

₹1,75,772

Returns

₹75,772

(+75.77%)

Returns from Zenas BioPharma, Inc. Stock

₹61,716 (+61.72%)

Dollar Impact

₹14,056 (+14.06%)

Analyst Recommendation on Zenas BioPharma, Inc. Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Zenas BioPharma, Inc.. Average target price of $43.4

Indian Investors' Interest in Zenas BioPharma, Inc. Stock

Search interest for Zenas BioPharma, Inc. Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Zenas BioPharma, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
5
10
-
-
-
-
1
Gross Profit
-22
-33
-33
5
10
-43
-5
-55
0
1
Operating Income
-27
-39
-40
-55
-37
-55
-52
-237
-77
-107
EBITDA
-27
-37
-38
-52
-33
-52
-51
-230
-74
-101
Interest Expense
-
-
-
-
-
-
-
-
6
10
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-37
-38
-52
-33
-52
-51
-240
-80
-111
Income Tax Expense
-
-
-
0
0
0
-
0
-
0
Net Income
-27
-37
-38
-52
-33
-52
-51
-240
-80
-111
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
100.00%

Zenas BioPharma, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
50
5
10
Gross Profit
-61
50
-134
10
Operating Income
-76
-37
-163
-211
EBITDA
-75
-27
-156
-370
Interest Expense
-
-
-
7
Depreciation
0
0
0
0
Income Before Tax
-119
-36
-156
-377
Income Tax Expense
-
0
0
0
Net Income
-119
-37
-156
-377
Net Profit Margin
0.00%
100.00%
-2682.78%
100.00%

Zenas BioPharma, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-27
-37
-38
-52
-33
-52
-51
-240
-80
-111
Operating Cash Flow
-19
-30
-31
-38
-37
-41
-41
-52
-75
-57
Investing Cash Flow
0
0
-26
-3
-86
-112
40
-93
31
-287
Financing Cash Flow
0
177
233
1
0
1
72
140
433
42
Change in Cash
-19
146
176
-40
-123
-152
71
-4
389
-303

Zenas BioPharma, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-119
-37
-156
-377
Operating Cash Flow
-65
-30
-119
-172
Investing Cash Flow
-2
0
-30
-251
Financing Cash Flow
59
20
412
215
Change in Cash
-8
-10
262
-209

Mutual Funds that own Zenas BioPharma, Inc. Stock

Check out the Mutual Funds with significant holdings in Zenas BioPharma, Inc..

Funds
Holdings
Shares Held
SMALLCAP World Fund Inc
3.734462%
2434000
Federated Hermes Equity Funds
3.416864%
2227000
Fidelity Securities Fund
2.970832%
1936291
Fidelity Select Portfolios
2.240677%
1460400
VANGUARD INDEX FUNDS
1.86131%
1213141
See all

Global Institutional Holdings in Zenas BioPharma, Inc.

Funds
Holdings
Peter Harwin
3.62%
Vanguard
2.51%
iShares
2.42%
James E. Flynn
2.4%
SPDR
2.35%
See all

Insights on Zenas BioPharma, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ZBIO stock has moved up by 61.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 456.8%

About Zenas BioPharma, Inc.

Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc"RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
OrganisationZenas BioPharma, Inc.
Headquarters852 Winter Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Leon Oliver Moulder Jr., M.B.A.
E-voting on sharesClick here to vote

Key Management of Zenas BioPharma, Inc.

Name

Title

Dr. Haley Laken Ph.D.

Chief Scientific Officer

Ms. Caroline Chevalier

Chief Administrative Officer

Mr. Jeffrey Held

Chief Legal Officer

Mr. Leon Oliver Moulder Jr., M.B.A.

Founder, CEO & Chairman

Mr. Joseph L. Farmer

COO & President

Dr. Lisa von Moltke M.D.

Head of Research & Development and Chief Medical Officer

Ms. Jennifer A. Fox

Chief Business Officer & CFO

Dr. Heinrich Schlieker Ph.D.

Chief Technical Officer

FAQs

What is Zenas BioPharma, Inc. share price today?

Zenas BioPharma, Inc. share price today is $31.47 as on . Zenas BioPharma, Inc. share today touched a day high of $31.91 and a low of $31.25.

What is the 52 week high and 52 week low for Zenas BioPharma, Inc. share?

Zenas BioPharma, Inc. share touched a 52 week high of $44.60 on and a 52 week low of $13.50 on . Zenas BioPharma, Inc. stock price today i.e. is trending at $31.47,which is 29.44% down from its 52 week high and 133.11% up from its 52 week low.

What is Zenas BioPharma, Inc.'s market capitalisation today?

Zenas BioPharma, Inc. market capitalisation is $0.00T as on .

How to invest in Zenas BioPharma, Inc. Stock (ZBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Zenas BioPharma, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zenas BioPharma, Inc. Shares that will get you 0.0477 shares as per Zenas BioPharma, Inc. share price of $31.47 per share as on September 18, 2026 at 11:42 pm IST.

What is the minimum amount required to buy Zenas BioPharma, Inc. Stock (ZBIO) from India?

Indian investors can start investing in Zenas BioPharma, Inc. (ZBIO) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Zenas BioPharma, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Zenas BioPharma, Inc. share’s latest price of $31.47 as on September 18, 2026 at 11:42 pm IST, you will get 0.3178 shares of Zenas BioPharma, Inc.. Learn more about fractional shares .